San Francisco, California 94143

  • Tobacco Use Disorder


The purpose of this study is to evaluate the extended pharmacological and psychological treatment for chronic cigarette smokers.

Study summary:

The work adapts interventions that have been successful in the general populations, and tailors them to chronic smokers, who may have numerous previous smoking treatment failures. If successful it will: (1) make available a treatment intervention that produces hight long term abstinence rates; (2) provide information on variables that predicts success and failure in this population of smokers; (3) examine the cost-effectiveness of more intensive, longer term treatments.


Subjects (N=400) will be men and women (50%) over the age of 18 who smoke at least 10 cigarettes per day and answers yes to the question "Do you smoke within 30 minutes of arising?" Inclusion Criteria: -Subjects are age 18 and over, currently smoking 10 or more cigarettes per day, and report a smoking history of at least 5 years in response to the question "How long have you been a regular smoker?" Exclusion Criteria: - History of seizure or head injury resulting in unconsciousness - Any condition that might predispose to seizures (brain tumor or stroke) - A current or history of anorexia nervosa or bulimia - Any disease acutely life-threatening or so severe that the patient is judged unable to comply with the protocol - Use of a protease inhibitor of MAO inhibitor within the last two week - Current use of psychiatric drugs that would interfere with interpretation of study results, including antidepressants - Treatment for alcohol dependence during the last year, or evidence of alcohol abuse so severe that the patient is judged potentially unable to comply with the protocol - Patients who know they are leaving the Bay Area within the study period and non-English speakers will be excluded - Suicidal or homicidal ideation - Current major depression - History of bipolar disorder - Recent (within twelve months) myocardial infarction - Any other medical condition that would contraindicate use of NRT or bupropion - Physical limitation so severe that participation in a program of moderate exercise is not possible - Pregnancy or lactation



Primary Contact:

Principal Investigator
Sharon M Hall, Ph.D.
University of California, San Francisco

Backup Contact:


Location Contact:

San Francisco, California 94143
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.